Early and late recurrent cardiovascular events among high‐risk patients with an acute coronary syndrome: Meta‐analysis of phase III studies and implications on trial design

BACKGROUND: Despite low‐density lipoprotein cholesterol‐lowering therapies and other standard‐of‐care therapy, there remains a substantial residual atherosclerotic risk among patients with an acute coronary syndrome (ACS). This study aims to estimate the risk of early and late recurrent major advers...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Gerald, Lee, Jane J., Kazmi, Syed H. A., Fitzgerald, Clara, Memar Montazerin, Sahar, Kalayci, Arzu, Korjian, Serge, Heise, Mark, Deckelbaum, Lawrence I., Libby, Peter, Bhatt, Deepak L., Gibson, C. Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922536/
https://www.ncbi.nlm.nih.gov/pubmed/35019162
http://dx.doi.org/10.1002/clc.23773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922536/
https://www.ncbi.nlm.nih.gov/pubmed/35019162
http://dx.doi.org/10.1002/clc.23773

Ejemplares similares